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Edited by Michael R. BubbAbstract Cytochrome c (CYT c) is a protein that employs the
caspase recruitment domain (CARD)-containing proteins
APAF-1 and CASP-9 to activate eﬀectors CASP-3 and -7. By
using aﬃnity labeling techniques and mass spectrometry analy-
sis, we show that histone H1.2 is a regulator of caspases upon
UV irradiation. We demonstrated that histone H1.2 forms a pro-
tein complex with APAF-1, CASP-9 and CYT c upon UV irra-
diation. In cell-free systems, we show that histone H1.2 triggers
activation of CASP-3 and -7 via APAF-1 and CASP-9. We
therefore conclude that upon DNA damage histone H1.2 acts
as a positive regulator of apoptosome formation.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Apoptotic cells typically exhibit a large number of morpho-
logical and biochemical changes, including DNA condensation
and degradation, loss of mitochondrial potential (DWm) and
cell shrinkage [1]. Upon intrinsic cell death signaling a set of
cysteinyl aspartases (caspases, CASP) and calcium-activated
endopeptidases (calpains, CAPN) become activated [2–4].
Most caspases regulate the apoptotic program through a
caspase activation cascade involving initiator CASP-1, -2, -9,
-11, -12 and eﬀector CASP-3 and -7 [3,5,6], which crosstalk
with CAPN-1 and -2 [4,7].
In response to DNA damage the proapoptotic protein cyto-
chrome c (CYT c) exits from the mitochondrial intermembrane
space to the cytoplasm and nucleus [8]. Fundamental and pio-
neer studies using cell-free systems have demonstrated that
CYT c is a regulatory protein that binds to the CED-4 like
adaptor protein APAF-1, generating a high molecular weight
protein complex termed apoptosome, which then activates the
initiator CASP-9 and CASP-3 and -7 [9,10]. CASP-9 requires
the physical interaction with APAF-1 to be activated, forming
thus a holoenzyme [11]. In vivo, the functional signiﬁcance of
APAF-1 and CASP-9 was validated inCasp-9/ and Apaf-1/
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damage in the form of UV irradiation, we carried out a proteo-
mic analysis to search for regulatory proteins of caspases. We
employed aﬃnity labeling techniques using the caspase inhibi-
tors (Ac-Tyr-Val-Lys-[biotinyl]-Asp-fmk) bound to an oligo-
meric irreversible streptavidin column. Mass spectrometry
analysis identiﬁed histone H1, H2A and H2B as regulators
of caspases. To further validate the role of these proteins in
the activation of caspases, we developed a novel non-hypo-
tonic cell-free system based on the zwitterionic detergent
CHAPS. Using this system we demonstrated that histone
H1.2, showed the capability to trigger CASP-3 and -7 in cell-
free systems. Biochemical analysis in Apaf-1/ and Casp-9/
cell protein extracts demonstrated that histone H1.2 speciﬁcally
requires APAF-1 and CASP-9 to activate downstream CASP-3
and -7. Finally, we demonstrated that histone H1.2 forms a pro-
tein complex with APAF-1, CASP-9 and CYT c upon UV irra-
diation. Thus, we conclude that proapoptotic histone H1.2 acts
as a positive regulator of apoptosome formation upon DNA
damage.2. Materials and methods
2.1. Cell culture
Murine embryonic ﬁbroblasts (MEFs) were derived from day 13.5
embryos of wild type (WT), Apaf-1/ [12], and Casp-9/ [14].
2.2. Western blot analysis
Total protein extracts were prepared by lysing cells in RIPA lysis
buﬀer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% sodium deoxy-
cholate, 0.1% sodium dodecyl sulfate, 1% Triton X-100, 1 mM phenyl-
methylsulfonyl ﬂuoride (PMSF), 2 mg/ml aprotinin, 2 mg/ml
leupeptin, 1 mg/ml pepstatin) for 10 min on ice. Cell debris was re-
moved by centrifugation (10000 · g, 10 min). Protein concentration
was measured using the BCA assay (Pierce). Samples (30 lg protein)
were resolved on a 4–12% gradient NuPAGE gel, transferred to PVDF
membranes, and blocked overnight with 5% non-fat dry milk in TBS
buﬀer (20 mM Tris–HCl pH 7.5, 150 mM NaCl). Subsequent antibody
incubations and membrane washes were performed in TBS-T buﬀer
(20 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.2% Tween 20) with 5%
non-fat dry milk. Antibodies were detected using enhanced chemolu-
minescence (Western Lightning, Perkin–Elmer).
2.3. S100ZWI and S8ZWI preparation
For S100ZWI fraction preparation, SV40 immortalized murine
embryonic ﬁbroblasts (MEFs) were collected, washed in PBS and then
resuspended in buﬀer A (100 mM HEPES, pH 7.2, 10% sucrose, 0.1%
3-[(3-cholamido propyl)dimethyl ammonio]-1-propanesulfonate, and
10 mMDTT) at 4 C for 20 min. After incubation, cells were disrupted
by Dounce homogenization, followed by 30 strokes through a 30-
gauge needle and then incubated 40 min at 4 C. Lysates were centri-
fuged (8000 · g, 20 min, 4 C), and the resulting supernatant furtherEuropean Biochemical Societies.
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cells were resuspended in buﬀer A (20 min, 4 C); after incubation, cells
were disrupted by 30 strokes through a 30-gauge needle. Lysates were
centrifuged (8000 · g, 20 min, 4 C), and the supernatant further cen-
trifuged (8000 · g, 20 min, 4 C).
2.4. Aﬃnity labeling and puriﬁcation
S100SWI fractions were pre-cleared with streptavidin–agarose
(Novagene) (2 h, 4 C), and then incubated with the caspase substrate
[Ac-Tyr-Val-Lys(biotinyl)-Asp-fmk] (Calbiochem) for 1 h at 4 C, after
that the samples were applied to an oligomeric streptavidin–agarose
column (1 h, 4 C). After extensive washing in buﬀer A, bound mate-
rial was eluted in 10 mM Tris, pH 7.5, 1% SDS and 100 mM 2-mercap-
toethanol at 95 C for 10 min. Samples were recovered by spinning
down (12000 · g, 1 min) and the resulting eluate was resolved on a
4–12% gradient NuPAGE gel, and then analyzed by silver staining
(Bio-Rad). Bands corresponding to UV-treated S100SWI fractions were
excised, and then analyzed by liquid chromatography and tandem
mass.
2.5. Immunoprecipitation
S100SWI fractions were pre-cleared with protein A/G-agarose (Santa
Cruz) (2 h, 4 C), incubated with 20 lg of anti-histone H1.2 antibody
overnight at 4 C, then applied to an protein A/G-agarose column
(2 h, 4 C). After washing in buﬀer A, bound material was eluted in
10 mM Tris, pH 7.5, 1% SDS and 100 mM 2-mercaptoethanol. The
resulting eluant was resolved on a 4–12% gradient NuPAGE gel, and
analyzed by silver staining (Bio-Rad). Western blots were revealed
using mouse TrueBlot ULTRA (HRP) anti-mouse IgG (eBioscience)
and TrueBlot (HRP) anti-rabbit IgG (eBioscience).
2.6. Caspase assays
Caspase activity was measured as indicated [3].
2.7. Histone H1.2-induced caspase activation
S8SWI fractions were incubated with 5 lM of histones and 1 mM
dATP (Sigma) at 37 C for 45 min. Sample were resolved on a 4–
12% gradient NuPAGE gel and transferred to PVDF membranes.
Western blotting was then performed to detect active CASP-3,
CASP-7 and CASP-9.2.8. Reagents
Recombinant H1.0, H1.2, H1.3, H1.4, H1.5 proteins were purchased
from Alexis. H2A and H2B were purchased from Upstate. Puriﬁed his-
tone H1 from calf thymus was purchased from Alexis. Puriﬁed CYT c
and dATP were from Sigma–Aldrich. UV light was induced using a
Stratalinker 2400 UV Crosslinker, 230 V (Stratagen).2.9. Antibodies
Antibodies for immunoblot analysis included mouse anti-actin mAb
(clone AC-15, Sigma–Aldrich), polyclonal rabbit anti-cleaved CASP-3
(#9661, Cell Signaling), rabbit anti-CASP-7 (#9492, Cell Signaling),
and rabbit anti-CASP-9 (#9504, Cell Signaling), rabbit anti-histone
H1.2 (ab17677, Upstate), mouse anti-CYT c (clone 7H82C12, Pharm-
ingen), anti-histone H3 (clone A35, Upstate), and rabbit anti-APAF-1
(#4452, Cell Signaling). We used HRP-conjugated anti-rabbit and
anti-mouse (DAKO).3. Results
Analysis of UV irradiation-induced DEVD-ase activity
(CASP-3 and CASP-7 activity) [15] in SV40 transformed mur-
ine embryonic ﬁbroblasts (SV40 MEFs) revealed a reproduc-
ible and marked peak 14 h post-treatment (Fig. 1A). To
identify unknown caspase regulators upon UV irradiation
(250 nm), we used aﬃnity labeling techniques with the irrevers-
ible caspase inhibitor (Ac-Tyr-Val-Lys-[biotinyl]-Asp-fmk) in
S100 fractions extracted using the zwitterionic detergent
CHAPS (S100ZWI fractions) (see Section 2). After a screeningof reliable experimental conditions, we optimized several pro-
tein puriﬁcation steps (Fig. 1B).
Fresh S100ZWI fractions from either untreated (negative con-
trol) or 14 h UV-irradiated cells (UV-14) were incubated with
the caspase inhibitor Ac-Tyr-Val-Lys-[biotinyl]-Asp-fmk, fol-
lowed by puriﬁcation on an oligomeric streptavidin column
(Fig. 1B). Interestingly, S100ZWI fractions from 14 h UV-irra-
diated cells [(UV-14)-S-100ZWI fractions] were speciﬁcally en-
riched in two bands corresponding to 20 and 34 kDa
(Fig. 1C). To determine their amino acid sequences, we per-
formed liquid chromatography and mass spectrometry analy-
sis [16,17]. Two tryptic fragments identical to mouse histone
H1 were found in the 34 kDa band (Fig. 1B), whereas three
peptides corresponding to mouse histone H2A and four pep-
tides for mouse histone H2B were detected in the 20 kDa band
(Fig. 1B). As expected, none of the enriched proteins in the
puriﬁcation were caspases, consistent with the irreversible
interaction of biotin with streptavidin [18] and active caspases
with the caspase inhibitor (Ac-Tyr-Val-Lys-[biotinyl]-Asp-
fmk) [5].
In our aﬃnity labeling experiments using S100ZWI fractions
from 14 h UV-irradiated cells, histone H3 and H4 were not
identiﬁed by mass spectrometry analysis. These results suggest
that nucleosome contamination from apoptotic cells in the
puriﬁcation step is thus unlikely. To test this hypothesis, we
analyzed the levels of histone H3 by Western blot in
S-100ZWI and (UV-14)-S-100ZWI fractions (Fig. 1D). As posi-
tive control, we checked the levels of histone H3 in total pro-
tein extracts (Fig. 1D). As histone H3 is not detected by
Western blot assay in both S-100ZWI and (UV-14)-S-100ZWI
fractions, we conclude that S-100ZWI and (UV-14)-S-100ZWI
fractions were not contaminated with nuclear proteins.
By using aﬃnity labeling pull-down experiments (Fig. 1C),
we show that histone H1 could form a protein complex with
active caspases, suggesting that histone H1 might regulate acti-
vation of caspases. To test this hypothesis, we analyzed
whether puriﬁed histone H1 from calf thymus could induce
caspase activation in cell-free systems. To this end, we em-
ployed two distinct cell-free systems; one based on S-100ZWI
fractions (soluble fractions after centrifugation at
100000 · g) and other based on S-8ZWI fractions (soluble frac-
tions after centrifugation at 8000 · g) (see Section 2). We ﬁrst
checked the levels of CYT c, CASP-9 and APAF-1 in S-8ZWI
and in S-100ZWI fractions by Western blot analysis (Fig. 2A).
Notably, the incubation of puriﬁed histone H1 plus dATP with
S-8ZWI fractions resulted in a marked CASP-3 activation
(Fig. 2B), indicating thus a role for histone H1 in caspase acti-
vation.
We also observed that incubation of puriﬁed histone H1 plus
dATP with S-100ZWI fractions resulted in low levels of CASP-3
activation (Fig. 2B); likely due to the low levels of soluble CYT
c and APAF-1 detected in those S-100ZWI fractions (Fig. 2A).
These data are in accordance with others [19–21] showing that
the relative amount of endogenous monomeric CYT c, APAF-
1 or CASP-9 in cytosolic extracts regulate the intensity of
apoptosome assembly and levels of caspase activation.
Since histone H1 present distinct variants (such as H1.0,
H1.2, H1.3, H1.4 and H1.5), we tested the ability of diﬀerent
recombinant histone H1 variants to induce caspase activity.
To this end, we analyzed CASP-3 and -7 activity upon incuba-
tion of recombinant histone H1.0, H1.2, H1.3, H1.4 or H1.5
with S-8ZWI fractions. As shown in the Fig. 2C, recombinant
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Fig. 1. Histone H1, H2A and H2B are candidate regulator of caspase activation. (A) SV40 transformed MEFs were UV-irradiated (250 nm) at
diﬀerent time points. After that CASP-3 and CASP-7 activities were measured as indicated [3]. (B) Summary of puriﬁcation steps. Brieﬂy, SV40-
MEFs are solubilized, thoroughly disrupted and agitated. Lysates are centrifuged to obtain S100ZWI fractions, then incubated with the caspase
substrate [Ac-Tyr-Val-Lys(biotinyl)-Asp-fmk]. S100ZWI fractions from untreated SV40 MEFs (control) and 14 h UV-irradiated SV40 MEFs (UV-14)
are then applied to an oligomeric streptavidin–agarose column and then the bound proteins eluted. (C) Samples from eluate in B was resolved on a 4–
12% gradient NuPAGE gel and silver-stained (Bio-Rad). Bands are shown for S100ZWI fractions from control, untreated SV40 immortalized MEFs
(left) and UV (250 nm)-treated SV40 immortalized MEFs (right), which were excised for liquid chromatography and tandem mass spectrometry
analysis. Mw indicates molecular weight. Sequence peptides are indicated in the ﬁgure. For complete experimental protocols, see Section 2. (D)
Western blot for histone H3 in S-100ZWI fractions and total protein extracts (RIPA extraction) from untreated and UV-irradiated cells. Actin was
used as loading control.
3424 A. Ruiz-Vela, S.J. Korsmeyer / FEBS Letters 581 (2007) 3422–3428H1.2, but not H1.0, H1.3, H1.4 or H1.5, showed the ability to
induce DEVD-ase activity in presence of dATP. Thus, all these
data together indicate that histone H1.2 speciﬁcally regulates
caspase activation.
We also analyzed the role of histone H2A and H2B in the
regulation of caspases, using histone H1.2 and CYT c as con-
trols. Addition of recombinant histone H1.2 plus dATP coop-
erated to induce CASP-3 processing in S8ZWI protein extracts,
whereas neither H2A nor H2B had eﬀect (Fig. 2D). Moreover,
we analyzed whether recombinant histone H1.2 plus dATP
could induce CASP-7 and CASP-9 activation (Fig. 2E). Our
results show that histone H1.2 speciﬁcally exhibits the ability
to trigger CASP-3, -7 and -9 activation.
Biochemical studies in hypotonic S-100 fractions have dem-
onstrated that oligomerization of APAF-1 and CASP-9 is pos-
itively regulated by CYT c plus dATP, [10]. We thereforetested whether recombinant histone H1.2, H2A and H2B could
initiate caspase activation in hypotonic S-100 fractions, using
puriﬁed CYT c as positive control. Incubation of the recombi-
nant proteins histone H1.2, H2A or H2B with hypotonic S100
fractions [9,10] in presence of dATP did not induced CASP-3
activation (Fig. 2F). These results imply that histone H1.2-in-
duced caspase activation requires putative cofactors that are
present in S-8ZWI fractions but not in hypotonic S-100 frac-
tions.
Next, we assessed the potential of histone H1.2 to induce
CASP-3, -7 and -9 in S8ZWI fractions from Apaf-1/ and
Casp-9/ SV40 immortalized MEFs, using wild type MEFs
as negative control. Addition of recombinant H1.2 plus dATP
to (WT)-S8ZWI extracts resulted in a simultaneous CASP-3, -7
and -9 proteolysis (Fig. 3). In contrast, histone H1.2 did not
promote CASP-3, -7 and -9 cleavage in absence of APAF-1
proCASP-3
p17
p19
Cytc + dATP
H2A  + dATP
H1.2 + dATP-
-
+-
- -
-
-
+
-
+
-
-
-
-
H2B  + dATP-+---
H1.2----+
S-8ZWI
Cytc + dATP
H2A  + dATP
H1.2 + dATP-
-
-+
- +
-
-
-
-
-
+
-
-
-
H2B  + dATP----+
H1.2+----
proCASP-3
p17
p19
Hypotonic S-100
+-
-+
H1.2 + dATP
dATP
proCASP-7
p20
proCASP-9
p37
C DEVD-ase activity
0 10 20 30 40 50 60 70 80 90 100
Control
dATP
Histone H1.0
Histone H1.2
Histone H1.3
Histone H1.4
Histone H1.5
Histone H1.0 + dATP
Histone H1.2 + dATP
Histone H1.3 + dATP
Histone H1.4 + dATP
Histone H1.5 + dATP
DEVD-pNA hydrolysis (Abs. 405 nm/a.u)
(CASP-3 and -7 activity)
A
proCASP-3
p17 (Cleaved CASP-3)
p19 (Cleaved CASP-3)
-+
+-
Histone H1 (Calf Thymus) + dATP
dATP
S-8ZWI
-+
+-
CASP-9
S-8ZWI
CYT c
B
APAF-1
S-100ZWI S-100ZWI
D E F
Fig. 2. Histone H1.2 induces caspase activation in presence of the zwitterionic detergent CHAPS (3-[(3-cholamido propyl) dimethyl ammonio]-1-
propanesulfonate). (A) Western blot for CYT c, APAF-1 and CASP-9 in S-8ZWI and S-100ZWI fractions. (B) S-100ZWI and S-8ZWI fractions were
incubated with puriﬁed histone H1 plus dATP or with dATP only, then samples were analyzed by Western blotting for anti-cleaved CASP-3. (C) S-
8ZWI fractions were incubated with recombinant H1.0, H1.2, H1.3, H1.4 or H1.5 in presence or in absence of dATP, then samples were analyzed for
CASP-3 and CASP-7 activities [3]. (D) S8SWI fractions were incubated with recombinant histones H1.2, H2A, H2B, or puriﬁed CYT c in presence of
dATP, then analyzed by Western blotting for active CASP-3. (E) S8SWI fractions were incubated with recombinant histones H1.2 only or in presence
of dATP, then analyzed by Western blotting for CASP-7 and CASP-9. (F) Hypotonic S100 fractions [9,10] were incubated with dATP and with
recombinant histones H1.2, H2A, H2B, or with CYT c (positive control), and then analyzed by Western blotting for active CASP-3.
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H1.2-induced CASP-3 and -7 requires APAF-1 and CASP-9
in cell-free systems.To understand the mechanism by which histone H1.2 trig-
gers caspase activation, we tested the interaction of CYT c
and APAF-1 with histone H1.2 in pull-down experiments
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resulting eluant was further analyzed by Western blot assay
using anti-histone H1.2, anti-CYT c and anti-APAF-1 anti-
bodies (Fig. 4A). Our data show that histone H1.2, CYT c
and APAF-1 interact with the caspase inhibitor Ac-Tyr-Val-
Lys-[biotinyl]-Asp-fmk upon UV irradiation, and suggest that
histone H1.2 might form a protein complex with APAF-1 and
CYT c.
To further corroborate the association of histone H1.2 with
APAF-1 and CYT c, we immunoprecipitated histone H1.2
proteins using anti-histone H1.2 antibodies in S-100ZWI frac-
tions from either untreated or 14 h UV-irradiated cells
(Fig. 4B). Upon immunoprecipitation, the resulting eluant
was evaluated by silver staining as well as by Western blot
analysis using anti-APAF-1, anti-CASP-9, anti-cleaved
CASP-3 and anti-CYT c antibodies (Fig. 4B). Our results show
that histone H1.2 interacts with components of the apopto-
some (such as APAF-1, CASP-9, CASP-3 and CYT c) upon
UV irradiation. Thus, by using two diﬀerent approaches (aﬃn-
ity labelling pull-down and immunoprecipitation techniques)
we have demonstrated that histone H1.2 forms a protein com-
plex with components of the apoptosome after UV irradiation.
These results are in agreement with the ability of histone H1.2
to trigger caspase activation in cell-free systems.4. Discussion
We performed a proteomic analysis to uncover regulatory
proteins of caspases in UV-irradiated cells. We employed the
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death regulators. Mass spectrometry analysis identiﬁed histone
H1, H2A and H2B as candidate regulators of caspases. As
shown in Fig. 1C, we found no active caspases in the elution
of the streptavidin column likely due to two irreversible inter-
actions that includes (1) the binding of active caspases with the
caspase inhibitor (Ac-Tyr-Val-Lys-[biotinyl]-Asp-fmk) [5], and
(2) the biotin interaction with the streptavidin column [18],
implying thus that elution of active caspases from the oligo-
meric streptavidin column is not viable. None of the enriched
proteins would thus be active caspases but rather regulatory
proteins, cofactors or associated proteins.
Human and mice have several histone H1 genes; all the H1
somatic histones (H1.1, H1.2, H1.3, H1.4 and H1.5) are ex-
pressed ubiquitously and are extremely similar in DNA se-
quence [22]. In a cell-free system based on cell solubilization
with the zwitterionic detergent CHAPS (3-[(3-cholamido pro-
pyl)dimethyl ammonio]-1-propanesulfonate) we demonstrated
that histone H1.2, but not other variants, induced CASP-3,
CASP-7 and CASP-9. Biochemical analysis in Apaf-1/ and
Casp-9/ cell extracts showed that histone H1.2 speciﬁcally
requires caspase recruitment domain (CARD)-containing pro-
teins APAF-1 and CASP-9 to initiate downstream CASP-3
and CASP-7.
We have compared the levels of CYT c in S-8ZWI fractions
(soluble fractions after centrifugation at 8000 · g) as well as
in S-100ZWI fractions (soluble fractions after centrifugation
at 100000 · g) by Western blot analysis (Fig. 2A). Our data
indicate that 0.1% of CHAPS can solubilize CYT c from mito-
chodria in SV40 transformed MEFs. Since CYT c was en-
riched in S-8ZWI fractions compared to S-100ZWI fractions
(Fig. 2A), these data suggest that most of the CYT c protein
is not present as monomeric protein in CHAPS-based buﬀers,
but forming a high molecular protein complex with other mito-
chondrial proteins [23]. In this regard, it has been shown that
CYT c interact with multiple mitochondrial components such
as the cytochrome bc1 complex [25], voltage-dependent anion-
selective channel (VDAC) [26], cytochrome b5 [27], NADPH
dependent diﬂavin oxidoreductase 1 [28] and cytochrome c oxi-
dase subunit IV isoform 2 [29].
Monomeric CYT c binds to APAF-1 in the absence of dATP
in hypotonic S-100 fractions [9,24]. Only when dATP is added
to hypotonic S-100 fractions the CYT c/APAF-1 protein com-
plex can assembly with CASP-9 to produce a higher molecular
weight protein complex called apoptosome [9,24]. Here, we
show that incubation of dATP only with S-8ZWI fractions is
not suﬃcient to trigger caspase activation (Fig. 2B). Therefore,
it is feasible that CYT c could be sequestered in a high molec-
ular mitochondrial protein complex impeding thus the correct
interaction with APAF-1 upon incubation with dATP only.
We show that incubation of dATP only with S-8ZWI frac-
tions (Fig. 2B, C, E) resulted in no discernible CASP-3,
CASP-7 and CASP-9 activation. Only when dATP was incu-
bated with puriﬁed histone H1 (Fig. 2B) or recombinant his-
tone H1.2 (Fig. 2C–E) we detected CASP-3, CASP-7 and
CASP-9 activation. Since histone H1.2 induces the release of
CYT c from isolated mitochondria [30], our results suggest
that histone H1.2-induced caspase activation in CHAPS-based
cell-free systems is the consequence of the exit of monomeric
CYT c from a putative mitochondrial protein complex, allow-
ing thus the formation of the apoptosome.Acknowledgement: A.R.V. was supported by a postdoctoral fellowship
from the European Molecular Biology Organization (EMBO).References
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